MedPath

HOme USability Evaluation

Not yet recruiting
Conditions
Cancer
Registration Number
NCT06134245
Lead Sponsor
Entia Ltd
Brief Summary

To validate the usability and safety of the Liberty Analyser.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Undergoing systemic anti-cancer therapy (SACT)
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at enrolment
  • Adequate English language skills (not requiring a translator) to participate in participant training and use the Entia Liberty analyser
  • Patients capable of providing written informed consent
Exclusion Criteria
  • History or current diagnosis of haematological malignancy
  • Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Entia Liberty analyser or participation in training
  • Inadequate use and understanding of the English language, requiring a translator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Entia Liberty Analyser is safe to useThrough study completion, 1 day

Results obtained using the Entia Liberty Analyser are valid and reliable

The Entia Liberty Analyser is easy to useThrough study completion, 1 day

Users can easily carry out a test using the Entia Liberty Analyser

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath